Cargando…

Molecular pathways in idiopathic pulmonary fibrosis pathogenesis: Transcending barriers to optimally targeted pharmacotherapies

Detalles Bibliográficos
Autores principales:	Strykowski, Rachel, Adegunsoye, Ayodeji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114113/ https://www.ncbi.nlm.nih.gov/pubmed/33965873 http://dx.doi.org/10.1016/j.ebiom.2021.103373

Ejemplares similares

Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease
por: Zhang, David, et al.
Publicado: (2023)

What Constitutes Family Ties? Exposures and Disease Phenotypes in Familial Pulmonary Fibrosis
por: Strykowski, Rachel K., et al.
Publicado: (2022)

Hospitalizations in patients with idiopathic pulmonary fibrosis
por: Kim, Hyun J., et al.
Publicado: (2021)

Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection–response to Guangting Zeng and Yuchi Zhou
por: Adegunsoye, Ayodeji, et al.
Publicado: (2023)

Trials and Treatments: An Update on Pharmacotherapy for Idiopathic Pulmonary Fibrosis
por: Thong, Lorraine, et al.
Publicado: (2023)

Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection: a prospective nationwide cohort study in the United States
por: Adegunsoye, Ayodeji, et al.
Publicado: (2023)

Inflammatory Response Mechanisms Exacerbating Hypoxemia in Coexistent Pulmonary Fibrosis and Sleep Apnea
por: Adegunsoye, Ayodeji, et al.
Publicado: (2015)

Pharmacotherapy for idiopathic pulmonary fibrosis: current landscape and future potential
por: Raghu, Ganesh
Publicado: (2017)

Dynamics in diagnoses and pharmacotherapy before and after diagnosing idiopathic pulmonary fibrosis
por: Davidsen, Jesper Rømhild, et al.
Publicado: (2020)

Olaparib: Transcending mutational barriers
por: Chandna, Abhishek
Publicado: (2019)

Idiopathic pulmonary fibrosis: pathogenesis and management
por: Sgalla, Giacomo, et al.
Publicado: (2018)

Idiopathic Pulmonary Fibrosis: An Update on Pathogenesis
por: Mei, Qianru, et al.
Publicado: (2022)

Dr. P. Namperumalsamy: Transitioning dreams, transcending barriers in accessible eye care
por: Das, Taraprasad, et al.
Publicado: (2022)

Divergent roles of the Hippo pathway in the pathogenesis of idiopathic pulmonary fibrosis: tissue homeostasis and fibrosis
por: Kizawa, Ryusuke, et al.
Publicado: (2023)

Inhaled Nitric Oxide for Fibrotic Interstitial Lung Disease: A Step Forward
por: Khor, Yet H., et al.
Publicado: (2022)

Idiopathic pulmonary fibrosis: moving forward
por: Richeldi, Luca
Publicado: (2015)

State of the Art in Idiopathic Pulmonary Fibrosis
por: El Agha, Elie, et al.
Publicado: (2022)

Transcending the self to transcend suffering
por: Ge, Brian H., et al.
Publicado: (2023)

One Molecule, Two Opposite Biological Effects: The Many Faces of Matrix Metalloproteases in the Pathogenesis of Idiopathic Pulmonary Fibrosis
por: Pardo, Annie, et al.
Publicado: (2021)

Skewed Lung CCR4 to CCR6 CD4(+) T Cell Ratio in Idiopathic Pulmonary Fibrosis Is Associated with Pulmonary Function
por: Adegunsoye, Ayodeji, et al.
Publicado: (2016)

Autophagy in Idiopathic Pulmonary Fibrosis: Predisposition of the Aging Lung to Fibrosis?
por: Zmijewski, Jaroslaw W., et al.
Publicado: (2022)

Clearing the Pathways to Self-Transcendence
por: Worth, Piers, et al.
Publicado: (2021)

Computer-Aided Pulmonary Fibrosis Detection Leveraging an Advanced Artificial Intelligence Triage and Notification Software
por: Selvan, Kavitha C., et al.
Publicado: (2023)

Toward Early Detection of Idiopathic Pulmonary Fibrosis
por: Schupp, Jonas Christian, et al.
Publicado: (2019)

Idiopathic pulmonary fibrosis management: caring is sparing
por: Nava, Stefano, et al.
Publicado: (2020)

A new direction in the pathogenesis of idiopathic pulmonary fibrosis?
por: Gauldie, Jack, et al.
Publicado: (2002)

Pathogenesis of idiopathic pulmonary fibrosis: review of recent findings
por: Renzoni, Elisabetta, et al.
Publicado: (2014)

Role of matrix metalloproteinases in the pathogenesis of idiopathic pulmonary fibrosis
por: Pardo, Annie, et al.
Publicado: (2016)

Genetics in Idiopathic Pulmonary Fibrosis Pathogenesis, Prognosis, and Treatment
por: Kaur, Amarpreet, et al.
Publicado: (2017)

Epithelial–Mesenchymal Transition in the Pathogenesis of Idiopathic Pulmonary Fibrosis
por: Salton, Francesco, et al.
Publicado: (2019)

Extracellular vesicles in idiopathic pulmonary fibrosis: pathogenesis and therapeutics
por: Fujita, Yu
Publicado: (2022)

The Role of Immune Cells in the Pathogenesis of Idiopathic Pulmonary Fibrosis
por: Xu, Yahan, et al.
Publicado: (2023)

The epithelium in idiopathic pulmonary fibrosis: breaking the barrier
por: Camelo, Ana, et al.
Publicado: (2014)

From Self-Transcendence to Collective Transcendence: In Search of the Order of Hierarchies in Maslow’s Transcendence
por: Llanos, Luis Felipe, et al.
Publicado: (2022)

Risk, Race, and Structural Racism
por: Valley, Thomas S., et al.
Publicado: (2021)

ATP12A: Connecting Mucus and Fibrosis in Idiopathic Pulmonary Fibrosis
por: Zabner, Joseph, et al.
Publicado: (2023)

Etiopathogenetic Mechanisms of Pulmonary Hypertension in Sleep-Related Breathing Disorders
por: Adegunsoye, Ayodeji, et al.
Publicado: (2012)

Guidelines or guidance for better idiopathic pulmonary fibrosis management?
por: Behr, Jürgen
Publicado: (2016)

Ironing Out the Roles of Macrophages in Idiopathic Pulmonary Fibrosis
por: O’Dwyer, David N., et al.
Publicado: (2019)

Another Weapon in the Battle against Idiopathic Pulmonary Fibrosis?
por: Wilson, Carole L., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_n42eu1o82nvha44bl2aipsnnic